Grant
PTH compounds with low peak-to-trough ratios
Applicants
- Ascendis Pharma Bone Diseases AS
[NORA names: Ascendis Pharma; Private Research]
Abstract
The present invention relates to a pharmaceutical composition comprising a PTH compound, wherein after subcutaneous administration the pharmacokinetic profile of the PTH compound exhibits a peak to trough ratio of less than 4 within one injection interval.
Patent Family Records (36)
![](/images/nora/info_circle_icon_160028.svg)
PTH Compounds with Low Peak-To-Trough Ratios
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2024, US-20240173385-A1
PTH compounds with low peak-to-trough ratios
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2024, US-11857603-B2
PTH compounds with low peak-to-trough ratios
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2024, AU-2017336251-B2
PTH Compounds with Low Peak-To-Trough Ratios
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, US-20230218722-A1
PTH compounds with low peak-to-trough ratios
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, US-11759504-B2
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGOE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, SI-3518961-T1
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, RS-64177-B1
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, PL-3518961-T3
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, LT-3518961-T
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES A SPROGE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, KR-20230170810-A
PTH compounds with low peak-to-trough ratios
아센디스 파마 본 디지즈 에이/에스 КАРПФ, Дэвид Брайан, СПРОГЕЕ, Кеннетт, ХОЛЬТЕН-АНДЕРСЕН, Ларс, (...more)
2023, KR-102611820-B1
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGOE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, HU-E062009-T2
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, HR-P20230383-T1
PTH compounds with low peak-to-valley ratios
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, ES-2943720-T3
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, EP-4218795-A3
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, EP-4218795-A2
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, EP-3518961-B1
PTH compounds with low peak to trough ratios
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, KARPF DAVID BRIAN, (...more)
2023, DK-3518961-T3
PTH compounds with low peak-to-valley ratio
Ascendis Pharma Bone Diseases AS SPROGOE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, CN-117257922-A
PTH compounds with low peak-to-valley ratio
Ascendis Pharma Bone Diseases AS SPROGOEE KENNETT, L. Holden-Anderson, D.B. Kapf
2023, CN-109789188-B
PTH COMPOUNDS WITH LOW PEAK-TO-MINIMUM RATIOS
Astsendis Farma Boun Dizizis A/S SPROGEE Kennett, KHOLTEN-ANDERSEN LARS, KARPF DEVID BRAJAN
2022, RU-2766959-C2
PTH compounds with low peak-to-trough ratios
Ascendis Pharma Bone Diseases AS KENNETT SPROGOE, LARS HOLTEN-ANDERSEN, DAVID BRIAN KARPF
2022, JP-2022116302-A
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2020, US-20200360488-A1
PTG CONNECTIONS WITH LOW PEAK TO MINIMUM RATIO
Асцендис Фарма Боун Дизизис А/С КАРПФ, Дэвид Брайан, СПРОГЕЕ, Кеннетт, ХОЛЬТЕН-АНДЕРСЕН, Ларс, (...more)
2020, RU-2019112919-A
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2019, ZA-201901813-B
PTH Compounds with Low Peak-To-Trough Ratios
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2019, US-20190282668-A1
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2019, SG-11201901558V-A
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS.
ASCENDIS PHARMA BONE DISEASES AS KENNETT SPROGØE, LARS HOLTEN-ANDERSEN, DAVID BRIAN KARPF
2019, MX-2019003182-A
PTH COMPOUNDS WITH LOW RELATIONSHIP BETWEEN PEAK AND MINIMUM LEVEL
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, KARPF DAVID BRIAN, (...more)
2019, MA-46345-A
PTH compound with low peak to trough ratio
ASCENDIS PHARMA BONE DISEASES A SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2019, KR-20190062497-A
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2019, EP-3518961-A1
PTH compound with low peak-to-valley ratio
Arsendis Drug Bone Disease Co Ltd SPROGOE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2019, CN-109789188-A
pth compounds with low peak-to-valley ratios
ASCENDIS PHARMA BONE DISEASES AS DAVID BRIAN KARPF, KENNETT SPROGØE, LARS HOLTEN-ANDERSEN
2019, BR-112019005793-A2
PTH compounds with low peak-to-trough ratios
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2019, AU-2017336251-A1
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2018, WO-2018060312-A1
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
Ascendis Pharma Bone Diseases AS SPROGOE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2018, CA-3037447-A1